
Transactions: Healthcare
Filter


Directed new share issue in Nordic Nanovector ASA (NO) — NOK 250 million

Private placement in Occlutech Holding AG (CH) — SEK 450 million

Rights issue in Targovax ASA (NO) — NOK 175 million

Directed new share issue in Paxman AB — SEK 77 million

Acquisition of Medrave Software AB (SE) by Carasent ASA (NO) — SEK 125 million

Directed share issue in NOVELDA AS (NO) — NOK 400 million

Initial public offering of Devyser Diagnostics AB (SE) on Nasdaq First North Premier Growth Market

Directed share issue in XVIVO Perfusion AB (SE) — SEK 250 million

Directed share issue in Ultimovacs ASA (NO) — NOK 270 million

Directed share issue in Lifecare AS (NO) — NOK 26 million
